Search

everythinglearnresearchcommunity

for

Search:↓

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

A global, inclusive approach is needed to address COVID-19 and protect vulnerable groups.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Most severe COVID-19 patients had hair loss, suggesting a possible link.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Social media data can help track and predict COVID-19 symptoms and trends.

Collider bias can distort our understanding of COVID-19 risk and severity.

Collider bias can mislead our understanding of COVID-19 risk and severity.

Age, health conditions, race, and gender affect COVID-19 risk.

Older age and existing health conditions increase COVID-19 death risk.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Insulin resistance linked to obesity may increase COVID-19 severity.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Pregnant women experience similar long-term COVID-19 symptoms as the general population.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Anti-androgens might help reduce COVID-19 severity in men.